Community-acquired bacteremia in HIV-positive patients: Protective benefit of co-trimoxazole

AIDS

Volumn 10, Issue 14, 1996, Pages 1635-1639

  Edge, Mark D ^a   Rimland, David ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Bacteremia; Co trimoxazole; HIV; Pneumocystis carinii; Prophylaxis

Indexed keywords

ANTIBIOTIC AGENT; CD4 ANTIGEN; COTRIMOXAZOLE; DAPSONE; PENTAMIDINE;

ARTICLE; BACTEREMIA; COHORT ANALYSIS; CONTROLLED STUDY; ESCHERICHIA COLI; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0029959358     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199612000-00007     Document Type: Article

References (20)

1. Whimbey E, Gold JWM, Poisky B, et al.: Bacteremia and fungemia in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1986, 104:511-514.
2. Krumholz HM, Sande MA, Lo B: Community-acquired bacteremia in patients with acquired immunodeficiency syndrome: clinical presentation, bacteriology and outcome. Am J Med 1989, 86: 776-779.
3. Norfelt DW: Bacteremia in persons with HIV infection. AIDS Clin Rev 1991:59-79.
4. Nelson MR, Shanson DC, Hawkins DA, Gazzard BG: Salmonella, Campylobacter and Shigella in HIV-seropositive patients. AIDS 1992, 6:1495-1498.
5. Meyer CN, Skinhoj P, Prag J: Bacteremia in HIV-positive and AIDS patients: incidence, species distribution, risk-factors, outcome, and influence of long-term prophylactic antibiotic treatment. Scand J Infect Dis 1994, 26:635-642.
6. Fichtenbaum C, Dunagan WC, Powderly W: Bacteremia in hospitalized patients infected with the human immunodeficiency virus: a case control study of risk factors and outcomes. J Acquir Immune Defic Syndr 1995, 8:51-57.
7. Manfredi R, Costiglioga P, Ricchi E, Chiodo F: Sepsis-bacteremia and other infections due to non-opportunistic bacterial pathogens in a consecutive series of 788 patients hospitalized for HIV infection. Clin Therapeut 1993, 143:279-290.
8. Wade JC, de Jongh CA, Newman KA, Crowley J, Wiernik PH, Schimpff SC: Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprimsulfamethoxazole vs. nalidixic acid. J Infect Dis 1993, 147:624-634.
9. EORTC International Antimicrobial Therapy Project Group: Trimethoprim-sulfamethoxazole in the prevention of infection in neutropenic patients. J Infect Dis 1984, 150:372-379.
10. Verhoet J: Prevention of infections in the neutropenic patient. Clin Infect Dis 1993, 17 (suppl 2):S359-S367.
11. Eng RHK, Yen K, Tecson-Tumang F, Smith SM, Akgun K: Risk of gram-negative bacteremia during neutropenia in patients with AIDS. Infect Dis Clin Prac 1994, 3:373-375.
12. Moore RD, Kerulye JC, Chaisson RE: Neutropenia and bacterial infection in acquired immunodeficiency syndrome. Arch Intern Med 1995, 155:1965-1970.
13. Centers for Disease Control and Prevention: USPHS/IDSA guide-lines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary. MMWR 1995, 44 (RR-8):5-24.
14. Hardy WD, Feinberg J, Finkelstein DM, et al.: A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: AIDS Clinical Trial Group protocol 021. N Engl J Med 1992, 327:1482-1488.
15. Mayer HB, Rose DN, Cohen S, Gurtman AC, Cheung TW, Szabo S: The effect of Pneumocystis carinii pneumonia prophylaxis regimens on the incidence of bacterial infections in HIV-infected patients [letter]. AIDS 1993, 7:1687-1689.
16. Stroud L, Srivastava P, Culver D, et al.: Nosocomial infections in HIV-infected patients: preliminary results from a multicenter surveillance system (1989-1995). Infect Control Hosp Epidemiol 1996 (in press).
17. Dean AC, Dean JA, Coulombier D, et al.: Epi Info, Version 6: A Word Processing, Database, Statistics Program for Epidemiology on Microcomputers. Atlanta: CDC; 1994.
18. Stanley HD, Charlebois E, Harb G, Jacobson MA: Central venous catheter infections in AIDS patients, J Acquir Immune Defic Syndr 1994, 7:272-278.
19. Autiuori A, Murri R, Ammassari A, et al.: Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. AIDS 1995, 9:1343-1350.
20. Bozzette SA, Finkelstein DM, Spector SA, et al.: A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. N Engl J Med 1995, 332:693-699.